Immunotherapy for lymphomas
/in International Publications, Malignant Lymphoma /von 2003-06-01 / Int. J. Hematol. 2003 Jun;77(5):444-55Recombinant Newcastle disease virus as a vaccine vector
/in International Publications, Newcastle Disease Virus /von 2003-06-01 / Poult. Sci. 2003 Jun;82(6):899-906Heat shock factor 1-independent activation of dendritic cells by heat shock: implication for the uncoupling of heat-mediated immunoregulation from the heat shock response
/in Hyperthermia, International Publications /von 2003-06-01 / Eur. J. Immunol. 2003 Jun;33(6):1754-62Hyperthermia improves cellular immune response to human hepatocellular carcinoma subsequent to co-culture with tumor lysate pulsed dendritic cells
/in Hepatocellular Carcinoma, International Publications /von 2003-06-01 / Int. J. Oncol. 2003 Jun;22(6):1397-402
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Das IOZK
Die IOZK Immuntherapie
Aktuelles und Int. Publikationen
- Recent developments in targeting breast cancer stem cells (BCSCs): a descriptive review of therapeutic strategies and emerging therapies
- Neoantigen-targeted dendritic cell vaccination in lung cancer patients induces long-lived T cells exhibiting the full differentiation spectrum
- Individualized Multimodal Immunotherapy (IMI): Scientific Rationale and Clinical Experience from a Single Institution